Duration of Contact Precautions in Acute Care Settings
Key Points
Key Points
Recommendations herein are based on synthesis of limited evidence, theoretical rationale, current practices, practical considerations, the opinion of the writing group, consideration of potential harms, and a survey of 134 institutions within the SHEA Research Network, 26% of which are outside the United States and Canada.
Methicillin-Resistant Staphylococcus aureus (MRSA)
...hicillin-Resistant Staphylococcus aur...
If a hospital uses CP for patients previous...
...t on antimicrobial therapy with acti...
...patients, such as those with chronic...
...outbreak setting, if a facility’s ende...
Vancomycin-Resistant Enterococci (VRE)
...ancomycin-Resistant Enterococci...
...a hospital uses CP when caring for pa...
...EA recommends that, following treatment o...
...should consider extending CP prior...
...an outbreak setting and if facility endemic rate...
Multidrug-Resistant Enterobacteriaceae (MDR-E)
...esistant Enterobacteriaceae (MDR-E)...
...al uses CP for patients infected or colonized with...
...nds that for extensively drug-resistant...
Clostridium difficile
Clostridium diffi...
...recommends that patients with C. di...
...als should consider extending CP through th...
...time, insufficient evidence exists to make a...
Microbiological Screening and Molecular Testing
...al Screening and Molecular Testing...
...me, insufficient evidence exists to...